Pablo Morales, MD

Dr. Pablo Morales leads the clinical and medical vision for Veranex’s iCRO business, shaping how we deliver innovative, patient-centered, and compliant solutions for our clients across all phases of development. He brings over 15 years of clinical, regulatory, and scientific leadership experience to his role as Chief Medical Officer at Veranex. Before joining Veranex, Dr. Morales served in senior leadership roles at the U.S. Food and Drug Administration (FDA), including Chief Medical Officer in the Office of Clinical Evidence and Analysis and Senior Medical Advisor in the Office of Clinical Policy. He provided clinical and regulatory oversight on more than 1,000 medical device submissions and played a key role in implementing the FDA’s Early Feasibility Studies (EFS) program. A trained vascular and endovascular surgeon, he earned his medical degree from Universidad Pontificia Bolivariana in Colombia, with advanced training at Guy’s and St. Thomas’ Hospital in London and a research fellowship at the Cleveland Clinic.